<?xml version="1.0" encoding="UTF-8"?>
<p id="p0180">Ribavirin shows broad spectrum 
 <italic>in vitro</italic> inhibitory activity against RNA viruses, through presumably different modes of action (
 <xref rid="b0270" ref-type="bibr">Leyssen et al., 2006</xref>, 
 <xref rid="b0415" ref-type="bibr">Severson et al., 2003</xref>, 
 <xref rid="b0500" ref-type="bibr">Zhou et al., 2003</xref>). In the case of alphaviruses, resistance mutants to ribavirin were mapped into the GTase domain of the nsP1 protein (
 <xref rid="b0385" ref-type="bibr">Scheidel et al., 1987</xref>, 
 <xref rid="b0390" ref-type="bibr">Scheidel and Stollar, 1991</xref>) suggesting ribavirin interferes with the GTase activity. Nevertheless, the ribavirin action mode remains controversial. Ribavirin also reduces the intracellular concentration of GTP (
 <xref rid="b0265" ref-type="bibr">Leyssen et al., 2005</xref>) and/or stimulates the expression of interferon-stimulated genes such as that of protein MDA5 (
 <xref rid="b0465" ref-type="bibr">Thomas et al., 2011</xref>), which is known to sense viral RNA devoid of 2’-O-methylation (
 <xref rid="b0125" ref-type="bibr">Decroly et al., 2012</xref>, 
 <xref rid="b0510" ref-type="bibr">Züst et al., 2011</xref>).
</p>
